Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
Sales | 3,413,000 | 3,445,000 | 3,301,000 | 3,247,452 | 2,931,943 |
Cost of Goods | 930,000 | 909,000 | 877,000 | 875,000 | 760,000 |
Gross Profit | 2,483,000 | 2,536,000 | 2,424,000 | 2,373,000 | 2,172,000 |
Operating Expenses | 1,525,000 | 1,674,000 | 1,492,000 | 1,626,000 | 1,298,000 |
Operating Income | 958,000 | 862,000 | 932,000 | 746,452 | 873,943 |
Interest Expense | 0 | 0 | 275,000 | -247,000 | 0 |
Other Income | 0 | 0 | 0 | -665,452 | 57 |
Pre-tax Income | 958,000 | 862,000 | 657,000 | 328,000 | 874,000 |
Income Tax | 269,000 | 254,000 | 0 | 230,000 | 253,000 |
Net Income Continuous | 689,000 | 608,000 | 657,000 | 98,644 | 620,817 |
Net Income | $689,000 | $608,000 | $657,000 | $98,644 | $620,817 |
EPS Basic Total Ops | 0.34 | 0.30 | 0.32 | 0.05 | 0.31 |
EPS Basic Continuous Ops | 0.34 | 0.30 | 0.32 | 0.05 | 0.31 |
EPS Diluted Total Ops | 0.34 | 0.30 | 0.32 | 0.05 | 0.31 |
EPS Diluted Continuous Ops | 0.34 | 0.30 | 0.32 | 0.05 | 0.31 |
EBITDA(a) | $958,000 | $862,000 | $932,000 | $746,452 | $873,943 |